It is also supported by the expression of Nfkb, an activator of ROS neurons, characteristic of AD patients, although it is also upregulated in animal cells treated with CSF from non-AD subjects, where an inflammatory effect is nevertheless observed. Here, NFKB1 is linked to Alzheimer disease.